Literature DB >> 16036481

Post-cycloplegia myopic shift in an older population.

Tze'Yo Toh1, Lisa S Kearns, Lindsey W Scotter, David A Mackey.   

Abstract

PURPOSE: To demonstrate that use of a mydriatic agent remains a significant confounder in autorefraction of the presbyopic population.
METHODS: The pre- and post-cycloplegic autorefraction results of 37 subjects over 50 years of age were measured using a Humphrey-598 autorefractor. The results of both eyes were included in a multivariate regression analysis.
RESULTS: The average age of the patient sample was 63.4 years. The mean spherical equivalent (SEQ) shifts for the hyperopic, myopic, pseudophakic, and emmetropic eyes were -0.53 D (95% CI -0.77 D to -0.39 D; p < 0.001), -0.38 D (95%CI -0.81 D to +0.04 D; p = 0.077), -0.49 D (95% CI -0.78 D to -0.20 D; p = 0.001), and -0.35 D (95% CI -0.59 D to -0.11 D; p = 0.004), respectively.
CONCLUSION: Cyclopleged autorefraction in the presbyopic population is associated with a myopic shift that can potentially lead to overestimation of myopic prevalence. This is an important factor in comparing population studies where cyclogleged autorefraction is used in contrast to non-cyclopleged autorefraction and subjective refraction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036481     DOI: 10.1080/09286580590964784

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  2 in total

1.  Twins eye study in Tasmania (TEST): rationale and methodology to recruit and examine twins.

Authors:  David A Mackey; Jane R Mackinnon; Shayne A Brown; Lisa S Kearns; Jonathan B Ruddle; Paul G Sanfilippo; Cong Sun; Christopher J Hammond; Terri L Young; Nicholas G Martin; Alex W Hewitt
Journal:  Twin Res Hum Genet       Date:  2009-10       Impact factor: 1.587

2.  Paradoxical myopic shift following cycloplegia in retinopathy of prematurity patients: a case series.

Authors:  Nikolas Js London; Susan M Carden; William V Good
Journal:  Cases J       Date:  2009-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.